Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Boundless Bio Inc. ( (BOLD) ).
On April 13, 2026, Boundless Bio, Inc. agreed to terminate its lease for approximately 80,168 square feet of laboratory and office space at 10955 Alexandria Way in San Diego, a lease that had originally been scheduled to run through October 31, 2034. Under the termination agreement with landlord ARE-10933 North Torrey Pines, LLC, the lease will end effective May 31, 2026, and the deal became effective once the landlord secured a replacement tenant for the premises.
As part of the arrangement, Boundless Bio will pay a $10 million lease modification fee and forfeit its roughly $0.5 million security deposit, representing a meaningful cash outlay to exit the long-term commitment. The move alters the company’s future facilities footprint and long-term lease obligations, with financial and operational implications for how it houses its laboratory and office functions going forward.
The most recent analyst rating on (BOLD) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Boundless Bio Inc. stock, see the BOLD Stock Forecast page.
Spark’s Take on BOLD Stock
According to Spark, TipRanks’ AI Analyst, BOLD is a Neutral.
The score is primarily constrained by weak financial performance typical of an early-stage, pre-revenue biotech (large ongoing losses and negative free cash flow despite some improvement). Technicals are broadly neutral to mildly positive, but valuation support is limited given negative earnings and no dividend yield.
To see Spark’s full report on BOLD stock, click here.
More about Boundless Bio Inc.
Boundless Bio, Inc. is a biotechnology company that operates laboratory and office facilities in San Diego, California, supporting its research and development activities in the life sciences sector. The company’s operations depend on specialized leased lab and office space to conduct its scientific and corporate work.
Average Trading Volume: 113,403
Technical Sentiment Signal: Sell
Current Market Cap: $25.32M
See more insights into BOLD stock on TipRanks’ Stock Analysis page.